8th Global Pharmaceutical Quality Summit 2023

Tags: Summits National News

The Indian Pharmaceutical Alliance (IPA) on 23 June successfully concluded the 8th edition of the Global Pharmaceutical Quality Summit at Mumbai.

An overview of the news

• The theme for the Summit was, ‘Patient Centricity: New Paradigm of Manufacturing and Quality’. 

• The two-day Summit brought together industry leaders, global regulators, quality experts, and stakeholders to foster knowledge exchange and deliberate on areas of importance in shaping the pharmaceutical landscape in India.

• The event was inaugurated by Samir Mehta, Chairman, Torrent Pharmaceuticals and President, IPA.

• Dr. Mansukh Mandaviya, Union Minister for Chemicals and Fertilizers and Health and Family Welfare addressed the summit.

• India played a vital role as the "Pharmacy to the World" during the COVID-19 pandemic by ensuring a steady supply of quality medicines and vaccines across the globe.

• The Indian pharmaceutical industry has demonstrated its potential both in terms of quality and quantity.

About the Indian Pharmaceutical Alliance (IPA)

• IPA was established in the year 1999 in Mumbai. 

• IPA represents 24 research-based national pharmaceutical companies.

• Collectively, the IPA companies contribute to over 85 percent of the private sector investment in pharmaceutical research and development in India.

• IPA companies are responsible for more than 80 percent of the country's exports of drugs and pharmaceuticals.

• They also serve over 60 percent of the domestic market in India.